Abbott Laboratories Raised its annual earnings guidance after posting higher than expected revenue from COVID-19 testing products.
Abbott, based in Abbott Park, Ill., now anticipates $6.1 billion in revenue from the sale of COVID tests this year, nearly a third more than its earlier projection. Most of those sales are already done. It expects just $500 million in sales over the next few months.